← FDA Drug Approvals (Drugs@FDA)

ISOTRETINOIN

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: AUROBINDO PHARMA LTD · Approved 2026-09-10

Drug application

FDA Application #
ANDA220336
Application type
Abbreviated New Drug Application (Generic)
Brand name
ISOTRETINOIN
Generic name
Isotretinoin
Active ingredients
ISOTRETINOIN
Dosage form
CAPSULE
Route
ORAL
Marketing status
Prescription
Sponsor
AUROBINDO PHARMA LTD
First approval
2026-09-10

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown